Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process

Ernst R. Berndt, Adrian H. B. Gottschalk, Tomas Philipson and Matthew W. Strobeck

A chapter in Frontiers in Health Policy Research, Volume 8, 2005 from National Bureau of Economic Research, Inc

JEL-codes: I18 K23 L65 (search for similar items in EconPapers)
Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process (2005)
Working Paper: Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process (2004)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:9874

Ordering information: This item can be ordered from
http://www.nber.org/chapters/c9874

Access Statistics for this chapter

More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().